Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bortezomib-Doxorubicin-Dexamethasone as Treatment for Patients With Multiple Myeloma Presenting With Acute Renal Failure

NCT00401804 is registered in ClinicalTrials.gov with Austrian Forum Against Cancer as lead sponsor.

NCT NCT00401804
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00401804 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bortezomib-Doxorubicin-Dexamethasone as Treatment for Patients With Multiple Myeloma Presenting With Acute Renal Failure
Lead sponsor
Austrian Forum Against Cancer
Phase
Phase 2
Overall status
Completed
Start date
February 28, 2006
Completion date
November 30, 2009
Enrollment
72 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

multiple myeloma, renal insuficiency